calendar
113 catalysts · 30 phase 2 completion · 23 phase 1 completion · 19 phase 1 2 completion · 14 phase 1 initiation · 9 phase 1 2 initiation · 4 phase 0 trial completion
next 91 dayslessmore
MonWedFri
113 catalysts · 30 phase 2 completion · 23 phase 1 completion · 19 phase 1 2 completion · 14 phase 1 initiation · 9 phase 1 2 initiation · 4 phase 0 trial completion
Therapy area: Oncology. Indication: Mesenchymal Tumor
Therapy area: Oncology. Indication: Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Metastatic Breast Cancer, Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Endometrial Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Metastatic Renal Cell Carcinoma
Therapy area: Infectious Disease. Indication: Helicobacter pylori Infections
Therapy area: Oncology. Indication: Soft Tissue Sarcoma
Therapy area: Oncology. Indication: Neuroblastoma
Therapy area: Infectious Disease, Mouth and Dental Disorders. Indication: Candidiasis, Xerostomia
Therapy area: Oncology. Indication: Prostate Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Small-Cell Lung Cancer